Your browser doesn't support javascript.
loading
TP53 DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Martire, Gaia; Lovisa, Federica; Carraro, Elisa; Rizzato, Domenico; Cesaro, Simone; Mura, Rosa Maria; Tondo, Annalisa; Bertolin, Cinzia; Boaretto, Francesca; Salviati, Leonardo; Biffi, Alessandra; Pillon, Marta; Mussolin, Lara.
Affiliation
  • Martire G; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
  • Lovisa F; Istituto di Ricerca Pediatrica Città della Speranza, Padova.
  • Carraro E; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
  • Rizzato D; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
  • Cesaro S; Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona.
  • Mura RM; Paediatric Hematology and Oncology Unit, Ospedale Pediatrico Microcitemico, Cagliari.
  • Tondo A; Department of Hematology-Oncology, Anna Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Firenze.
  • Bertolin C; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
  • Boaretto F; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
  • Salviati L; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
  • Biffi A; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
  • Pillon M; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
  • Mussolin L; Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova. lara.mussolin@unipd.it.
Haematologica ; 109(9): 3031-3036, 2024 Sep 01.
Article in En | MEDLINE | ID: mdl-38385281
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Burkitt Lymphoma / Rituximab / Mutation Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Burkitt Lymphoma / Rituximab / Mutation Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication: Italia